title: Obstructive sleep apnea in pregnancy and fetal outcome.
abstract: OBJECTIVE
  To simultaneously investigate the polysomnography (PSG) and nonstress test (NST) records of pregnant women with obstructive sleep apnea (OSA) to observe NST changes during maternal desaturation and determine maternal and fetal outcomes.
  
  
  METHODS
  A prospective observational study of pregnant women assessed by questionnaire for symptoms of OSA. Women with self-reported frequent snoring or apnea were offered PSG and NST.
  
  
  RESULTS
  OSA was diagnosed in 4 (11.4%) of the 35 pregnant women who underwent PSG. Three (75%) had fetal heart decelerations accompanying maternal desaturation. The neonates of women diagnosed with OSA had lower mean Apgar scores and birth weights compared with neonates of women without OSA. Three neonates from the women diagnosed with OSA were admitted to the newborn healthcare unit.
  
  
  CONCLUSIONS
  OSA in pregnancy has important maternal and fetal outcomes. Pregnant women should be assessed for symptoms of OSA and suspected cases should be offered PSG.
authors.affiliation: Department of Obstetrics and Gynecology, Faculty of Medicine, Afyonkarahisar Kocatepe University, Afyonkarahisar, Turkey. drfigenkir@yahoo.com
authors.forename: Figen Kir
authors.initials: FK
authors.lastname: Sahin
authors.forename: Gulengul
authors.initials: G
authors.lastname: Koken
authors.forename: Emine
authors.initials: E
authors.lastname: Cosar
authors.forename: Filiz
authors.initials: F
authors.lastname: Saylan
authors.forename: Fatma
authors.initials: F
authors.lastname: Fidan
authors.forename: Mehmet
authors.initials: M
authors.lastname: Yilmazer
authors.forename: Mehmet
authors.initials: M
authors.lastname: Unlu
mesh_terms: D001034:Apgar Score; D015148:Cardiotocography; D015331:Cohort Studies; D005260:Female; D006340:Heart Rate, Fetal; D006801:Humans; D007231:Infant, Newborn; D017286:Polysomnography; D011247:Pregnancy; D011248:Pregnancy Complications; D011256:Pregnancy Outcome; D020181:Sleep Apnea, Obstructive / Q000150:complications*